Welcome to to the Irish Medical Times website
This site is aimed at healthcare professionals.
Are you a healthcare professional?
Yes
No
This site contains information, news and advice for healthcare professionals.
You have informed us that you are not a healthcare professional and therefore we are unable to provide you with access to this site.

August 21, 2014

Aspirin

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport permitted. Active ingredient: Acetylsalicylic acid (aspirin) 75mg. Description: Oval, white, biconvex film-coated, gastro-resistant tablets. Presentation: 28, €0.95. Indications: Secondary prevention of myocardial infarction (MI), prevention of cardiovascular morbidity in stable angina pectoris, history of unstable angina pectoris (except during acute phase), prevention of graft occlusion after […]

Bufomix Easyhaler

Company: Orion Pharma (Ireland) Ltd. Legal category: Prescription. GMS. Sport restricted β2 agonists. Active ingredient: Budesonide/formoterol (fumarate dihydrate) 160/4.5mcg, 320/9mcg per delivered dose. Description: Inhalation powder. Presentation: 160/4.5mcg, 120-dose unit: €29.50; 320/9mcg, 60-dose unit: €29.50. Indications: Regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate. Symptomatic […]

Rowalief

Company: Rowa. Legal category: OTC. Sport permitted. Active ingredient: Rowalief: Paracetamol 500mg. Rowalief Max: Paracetamol 1000mg. Description: White, caplet shaped, film-coated tablets with a breakline on one side. 500mg: P and 500 on one side. 1000mg: Biconvex. Presentation: 500mg-12, €1.30; 500mg-24, €1.80; 1000mg-10, €3.50. Indications: Symptomatic treatment of mild to moderate pain and fever. Pharmacology: […]

Telmisartan/HCTZ Clonmel

Company: Clonmel Healthcare Ltd. Legal category: Prescription. GMS. Sport prohibited. Active ingredients: Telmisartan/hydrochlorothiazide 40/12.5mg, 80/12.5mg, 80/25mg. Description: White tablets. 40/12.5mg, 80/25mg: Oval shaped, biconvex marked TH on one side. 80/25mg: Marked 25 on reverse. 80/12.5mg: Capsule shaped, marked TH 12.5 on both sides. Presentation: 40/12.5mg-28, €6.47; 80/12.5mg-28, €8.18; 80/25mg-28, €8.39. Indication: Treatment of essential hypertension […]

Zostavax

Company: Sanofi Pasteur MSD. Legal category: Prescription. Sport permitted. Active ingredient: Live, attenuated varicella-zoster virus (Oka/Merck strain) ≥19400 PFU per 0.65ml. Description: Powder and solvent for suspension for injection in pre-filled syringe. Presentation: Vial and prefilled syringe, price available on request. Indications: Prevention of herpes zoster (shingles) and herpes zoster-related post-herpetic neuralgia in adults over […]

Assessment of Cancer Pain: ESMO Guidelines

Table 1. Adequate Assessment of the Patient with Cancer Pain at any stage of the Disease: ESMO Guidelines Download PDF: Assessment of Cancer Pain   1. Assess and re-assess the pain Causes, onset, type, site, absence/presence of radiating pain, duration, intensity, relief and temporal patterns of the pain, number of breakthrough pains, pain syndrome, inferred […]

Treatment of Cancer Pain

Algorithm for Treament of Cancer Pain Download PDF: Treament of Cancer Pain   Click on image to enlarge   See also: Assessment of Cancer Pain: ESMO Guidelines Reference: 1 – Ripamonti et al. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol. 23 (Suppl. 7): vii139-154, 2012.

Immunotherapies for Multiple Sclerosis – Cochrane Review

Comparative Efficacy and Risk-Benefit Balance of Immunotherapies for Multiple Sclerosis Download PDF Merck Serono wish to highlight the results of a Cochrane review designed to estimate the efficacy and acceptability of different immunotherapies commonly used in people with multiple sclerosis (MS).1 Eleven agents were studied, interferon ß-1b (IFNß-1b), IFNß-1a SC (Rebif) and IFNß-1a IM, glatiramer […]

Medicines Affecting the Renin-Angiotensin (RAS) System

Recommendation to Restrict the Combined Use of Medicines Affecting the Renin-Angiotensin (RAS) System The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the risks of combining different classes of medicines that act on the RAS system. These medicines, which are called RAS-acting agents, belong to three classes: 1. Angiotensin-receptor blockers (ARBs) for example […]

Pathophysiology of Erectile Dysfunction

Download PDF: Pathophysiology of ED Vasculogenic Cardiovascular disease – Hypertension – Diabetes mellitus – Hyperlipidaemia – Smoking – Major surgery (RP) or radiotherapy (pelvis or retroperitoneum) Neurogenic Central causes – Degenerative disorders (multiple sclerosis, Parkinson’s disease, multiple atrophy etc.) – Spinal cord trauma or diseases – Stroke – Central nervous system tumours Peripheral causes – […]

Next Page »